文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

基于社区参与式研究模型的同伴小组治疗对糖尿病和/或高血压患者服药依从性的有效性:印度农村多中心整群随机试验研究方案(PARTICIPATE研究)

Effectiveness of peer-group therapy using community based participatory research model on medication adherence among patients of diabetes and/or hypertension: study protocol for a multi-centre cluster randomised trial in rural settings across India (PARTICIPATE study).
PubMed 文献 · Trials · 2025-11-06

该研究为在印度4个地区4个区块(64个村庄)开展的多中心整群随机试验,纳入2880名随机选取的糖尿病和/或高血压成人,评价基于社区参与式研究(CBPR)的同伴教育者干预对服药依从性(MMAS-8)的影响,干预为期12个月,对照组接受常规照护。

要点

  • 研究在印度农村4个区块64个村庄开展多中心整群随机试验,纳入2880名随机选取的糖尿病和/或高血压成人。
  • 干预由社区识别的同伴教育者实施,为期12个月,前6个月后接着每月一次会话持续6个月。
  • 主要结局为基线和中期及结束时自报MMAS-8测定的服药依从性,并控制社会经济状况等独立变量。

核心结论

  • 据作者所知,这是印度首个评估CBPR方法改善糖尿病和高血压患者服药依从性有效性的多中心整群随机对照试验,结果将为印度及类似中低收入国家扩大同伴教育者模式提供证据基础。

研究设计与样本

  • 多中心整群随机试验,在印度东、西、北、南4个地区各1个区块共4个区块(64个村庄)实施,覆盖2880名随机选取的参与者。
  • 嵌套经济评估将测量社区参与式研究(CBPR)的有效性。
  • 干预由从社区识别的同伴教育者实施,为期12个月,前6个月后接着每月一次会话持续6个月。
  • 对照组继续接受医疗保健提供者(公立或私立)提供的所有方面常规照护。

主要发现

  • 主要结局变量为基线和中期及结束时自报Morisky服药依从性量表(MMAS-8)测定的高血压和/或糖尿病服药依从性。
  • 分析中将控制独立变量:社会经济状况、抗高血压和/或抗糖尿病药物数量及其持续时间、自感健康状况、收缩压和舒张压和/或HbA1c。
  • 次要结局包括使用全面健康素养量表(AAHS)的健康素养改善、临床结局、使用EURO-QoL(EQ-5D)的生活质量、成本效果和投资回报率(ROI)。
  • 将对参与者子样本进行过程评估,以检查对各种干预成分的参与情况。
  • 干预保真度将使用规范化过程理论框架进行监测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: According to the WHO, more than 50% of patients do not take their medications as prescribed. Nonadherence is caused by several variables, including social and economic factors, issues with the healthcare team and system, problems related to specific diseases, characteristics of those diseases, and their treatments. OBJECTIVE: To study the effectiveness of the PARTICIPATE intervention at the community level regarding medication adherence among adults with diabetes and/or hypertension in rural India. STUDY DESIGN: This is a multicentre cluster randomised trial implemented across 4 blocks (64 villages) of 4 districts in East, West, North, and South India, covering 2880 randomly selected participants. A nested economic evaluation will measure the effectiveness of community-based participatory research (CBPR). The intervention will be delivered by peer educators identified from the community for a duration of 12 months, with the first 6 months followed by monthly sessions for the next 6 months. The control group will continue to receive all aspects of standard care offered by healthcare providers (public or private). METHODS: The measure of drug adherence for hypertension and/or diabetes, as determined by the self-reported Morisky Medication Adherence Scale (MMAS-8) at baseline, midterm, and end, is the study's outcome variable. The independent variables, namely socio-economic status, number of antihypertensive and/or antidiabetic drugs, their duration, self-perceived health status, systolic and diastolic blood pressure, and/or HbA1c, will be controlled for during the analysis. Secondary outcomes include improvement in health literacy using the All Aspects of Health Literacy Scale (AAHS), clinical outcomes, quality of life using the EURO-QoL (EQ-5D), cost-effectiveness, and return on investment (ROI). Process evaluations will be conducted with a sub-sample of participants to examine engagement in various intervention components. The fidelity of intervention will be monitored using the Normalisation Process Theory framework. DISCUSSION: To the best of our knowledge, this is the first multi-centre cluster randomised controlled trial in India to assess the effectiveness of the CBPR approach for improving medication adherence among diabetics and hypertensive patients. The results of this study will contribute to the evidence base for scaling up peer-educator models for diabetes and hypertension management in India and similar low- and middle-income countries. TRIAL REGISTRATION: The registration number for this trial is CTRI/2024/01/061939.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Reddy P, Jha A, Gupta H, et al. Effectiveness of peer-group therapy using community based participatory research model on medication adherence among patients of diabetes and/or hypertension: study protocol for a multi-centre cluster randomised trial in rural settings across India (PARTICIPATE study). Trials. 2025. PMID: 41199367. doi:10.1186/s13063-025-09209-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。